The Latest Breaking News from Nasdaq

Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN).

ESSA Pharma Inc (NASDAQ:EPIX) presented clinical results from the Phase 1a dose-escalation study of EPI-7386 as a monotherapy for metastatic castration-resistant prostate cancer (mCRPC) resistant to current standard-of-care therapies.  The initial data from 36 patients demonstrate that EPI-7386 was well-tolerated, exhibited a favorable pharmacokinetic profile, and demonstrated initial anti-tumor activity in a heavily…

Some of the stocks that may grab investor focus today are:

A spokesperson for Rep. Nancy Pelosi (D- Calif.) said the House Speaker was not trying to push aside Rep. Mayra Flores's (R-Texas) child at a photo op during Flores' swearing-in ceremony last week but was instead was trying to make sure she would not be hidden.

Shares of major U.S.-listed Chinese companies were trading lower in Hong Kong on Tuesday, with major tech stocks like Alibaba Group Holdings (NYSE: BABA), Tencent Holdings (OTC: TCEHY), Baidu Inc (NASDAQ: <

Tesla Inc (NASDAQ: TSLA) will face a new trial related to the damages that it owes to a Black former factory worker after he turned down a $15 million award in a race discrimination lawsuit, Reuters

Prince Harry and Meghan Markle have reportedly hired “Lost Girls” fame director Elizabeth Freya Garbus to direct their Netflix Inc (NASDAQ: NFLX) reality television program. 

The world’s richest man has one of the most followed accounts on the social media platform Twitter Inc (NYSE: TWTR): Elon Musk passed a milestone Monday for his Twitter account.

There was good news and bad news from Warner Bros.’ (NASDAQ: WBD) biopic “Elvis” premiere engagement this weekend in U.S. theaters.